Aerosol Therapy in Infants and Children: Special Considerations

Research output: Chapter in Book/Conference paperChapter

Abstract

Delivering drugs to infants and children can be a significant challenge. The devices currently available have been developed primarily for adults and have been modified or adapted for young children. As with patients of all age groups, drugs can have adverse side effects as well as therapeutic effects, and it is important to select devices and accessories that will maximize delivery to the lungs while minimizing extra-pulmonary deposition. Numerous factors influence pulmonary drug delivery such as characteristics of the aerosol delivery system, use of the device by the patient, variations in airways geometry, and disease of the upper and lower airways. In cooperative subjects, data suggests the within-subject coefficient of variation is similar to that seen in adults. Many of those dealing with patients are generally aware of the challenges of optimizing drug delivery at the different stages of development, although unfortunately this is far from universal. For those not dealing directly with patients, it is vital that the impact of developmental physical and mental issues are understood when considering the development of novel devices or the use of new chemical entities, if reliable delivery of drug to the lungs is to be
achieved.
Original languageEnglish
Title of host publicationISAM Textbook of Aerosol Medicine
EditorsRajiv Dhand
Chapter11
Pages985-1006
Number of pages22
ISBN (Electronic)978-0-9963711-0-0
Publication statusPublished - 2016

Fingerprint

Aerosols
Equipment and Supplies
Lung
Pharmaceutical Preparations
Therapeutics
Therapeutic Uses
Age Groups

Cite this

Devadason, S., & Everard, M. (2016). Aerosol Therapy in Infants and Children: Special Considerations. In R. Dhand (Ed.), ISAM Textbook of Aerosol Medicine (pp. 985-1006). [11.2]
Devadason, Sunalene ; Everard, Mark. / Aerosol Therapy in Infants and Children: Special Considerations. ISAM Textbook of Aerosol Medicine. editor / Rajiv Dhand. 2016. pp. 985-1006
@inbook{d1366d98bfc646629c193456e72b1839,
title = "Aerosol Therapy in Infants and Children: Special Considerations",
abstract = "Delivering drugs to infants and children can be a significant challenge. The devices currently available have been developed primarily for adults and have been modified or adapted for young children. As with patients of all age groups, drugs can have adverse side effects as well as therapeutic effects, and it is important to select devices and accessories that will maximize delivery to the lungs while minimizing extra-pulmonary deposition. Numerous factors influence pulmonary drug delivery such as characteristics of the aerosol delivery system, use of the device by the patient, variations in airways geometry, and disease of the upper and lower airways. In cooperative subjects, data suggests the within-subject coefficient of variation is similar to that seen in adults. Many of those dealing with patients are generally aware of the challenges of optimizing drug delivery at the different stages of development, although unfortunately this is far from universal. For those not dealing directly with patients, it is vital that the impact of developmental physical and mental issues are understood when considering the development of novel devices or the use of new chemical entities, if reliable delivery of drug to the lungs is to beachieved.",
author = "Sunalene Devadason and Mark Everard",
year = "2016",
language = "English",
pages = "985--1006",
editor = "Rajiv Dhand",
booktitle = "ISAM Textbook of Aerosol Medicine",

}

Devadason, S & Everard, M 2016, Aerosol Therapy in Infants and Children: Special Considerations. in R Dhand (ed.), ISAM Textbook of Aerosol Medicine., 11.2, pp. 985-1006.

Aerosol Therapy in Infants and Children: Special Considerations. / Devadason, Sunalene; Everard, Mark.

ISAM Textbook of Aerosol Medicine. ed. / Rajiv Dhand. 2016. p. 985-1006 11.2.

Research output: Chapter in Book/Conference paperChapter

TY - CHAP

T1 - Aerosol Therapy in Infants and Children: Special Considerations

AU - Devadason, Sunalene

AU - Everard, Mark

PY - 2016

Y1 - 2016

N2 - Delivering drugs to infants and children can be a significant challenge. The devices currently available have been developed primarily for adults and have been modified or adapted for young children. As with patients of all age groups, drugs can have adverse side effects as well as therapeutic effects, and it is important to select devices and accessories that will maximize delivery to the lungs while minimizing extra-pulmonary deposition. Numerous factors influence pulmonary drug delivery such as characteristics of the aerosol delivery system, use of the device by the patient, variations in airways geometry, and disease of the upper and lower airways. In cooperative subjects, data suggests the within-subject coefficient of variation is similar to that seen in adults. Many of those dealing with patients are generally aware of the challenges of optimizing drug delivery at the different stages of development, although unfortunately this is far from universal. For those not dealing directly with patients, it is vital that the impact of developmental physical and mental issues are understood when considering the development of novel devices or the use of new chemical entities, if reliable delivery of drug to the lungs is to beachieved.

AB - Delivering drugs to infants and children can be a significant challenge. The devices currently available have been developed primarily for adults and have been modified or adapted for young children. As with patients of all age groups, drugs can have adverse side effects as well as therapeutic effects, and it is important to select devices and accessories that will maximize delivery to the lungs while minimizing extra-pulmonary deposition. Numerous factors influence pulmonary drug delivery such as characteristics of the aerosol delivery system, use of the device by the patient, variations in airways geometry, and disease of the upper and lower airways. In cooperative subjects, data suggests the within-subject coefficient of variation is similar to that seen in adults. Many of those dealing with patients are generally aware of the challenges of optimizing drug delivery at the different stages of development, although unfortunately this is far from universal. For those not dealing directly with patients, it is vital that the impact of developmental physical and mental issues are understood when considering the development of novel devices or the use of new chemical entities, if reliable delivery of drug to the lungs is to beachieved.

M3 - Chapter

SP - 985

EP - 1006

BT - ISAM Textbook of Aerosol Medicine

A2 - Dhand, Rajiv

ER -

Devadason S, Everard M. Aerosol Therapy in Infants and Children: Special Considerations. In Dhand R, editor, ISAM Textbook of Aerosol Medicine. 2016. p. 985-1006. 11.2